about
Cancer Risk in Patients With Empyema: A Nationwide Population-Based StudyDelayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based studyRheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study.The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study.Hyperthyroidism and risk for bipolar disorders: a nationwide population-based studyRisk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based studyRisk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.Outcome disparities between medical personnel and nonmedical personnel patients receiving definitive surgery for colorectal cancer: a nationwide population-based studySecondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.Risk of cancer among patients with herpes zoster infection: a population-based study.Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study.Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.Salvage treatment for recurrent intracranial germinoma after reduced-volume radiotherapy: a single-institution experience and review of the literature.The pattern of failure and predictors of locoregional control in lateralized buccogingival cancer after postoperative radiation therapy.Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and eventual adjuvant treatment: The potential role of chemotherapy.Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease.Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.Association of surgeon volume and hospital volume with the outcome of patients receiving definitive surgery for colorectal cancer: A nationwide population-based study.Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.Amyloidosis and the risk of cancer: a nationwide population-based study.Risk and impact of tuberculosis in patients with chronic myeloid leukemia: a nationwide population-based study in Taiwan.Correction: Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.Definitive Radiotherapy for Older Patients with Prostate Cancer: Experience of a Medical Center in TaiwanIncreased cancer risk in patients with haemophilia A: a nationwide population-based 14-year study in Taiwan.Risk of cancer in children, adolescents, and young adults with autistic disorder.Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: A national-based cohort study.Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction.Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients.Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments.Real-World Role of Adjuvant Chemotherapy in Bladder Cancer.Chinese herbal medicine use and risk of end-stage renal disease in patients with chronic kidney disease: is there an immortal time bias?Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7.Risk of Breast Cancer in Patients with Thyroid Cancer Receiving 131I Treatment: Is There an Immortal Time Bias?Statins and the risk of pancreatic cancer in Type 2 diabetic patients: Immortal time bias in survival analysis?Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.Is 1-year follow-up adequate for adult tuberculosis contacts?
P50
Q27315538-7FA8B6CA-FFFE-4C42-A931-57C3628DD81CQ28535127-56D4209E-5320-4B82-8D6D-D4C71A806DA9Q34206659-5376F2C7-8885-470F-85F4-DD424C57EA78Q34608546-9AC41048-B8D8-4F98-B05C-E17260446F5BQ34983698-677ACC6E-10D4-4114-8AC8-56F8178BC61FQ35095535-AFFE4CCF-5717-459E-9A49-43FA7120F63EQ35928283-08456DD6-4628-4424-AA6E-469E09EA26E8Q35976536-D76623C9-AAF7-4991-95C9-6AC90304E58DQ36153260-18F47D81-C228-4372-8FFB-684CD03D8232Q36256006-C42D6827-0AEB-4075-A0AA-B87F67F9DFC9Q36338920-5D264626-4D6F-4D4C-9F46-F10AC8D39251Q36566759-CB836F0B-7C75-4F2A-884C-64DDE58BF8D5Q37003350-4F96D673-7A32-474D-9297-CBDB5C817B15Q37176188-FC4F5878-A9BA-4E1C-86A0-86D8E1265BE9Q37987666-F9C954FA-2EC4-428B-B03C-4F1ADC0154D5Q38689116-14E371EC-6C64-49A9-9859-98BE5DD2C942Q38770355-175E3580-3871-4864-93C5-E719DECC0BC1Q39473320-55FDDFC5-EDC7-479D-8B69-9F40B25AD5DEQ40765651-AD5BA7C3-D607-4290-B12B-C6F3B0A5B5C6Q40942679-FEF3DFFC-E467-4A7E-8BB1-5D2937D71887Q41041776-C4EA965A-BE97-4DBF-84FB-7F2683D23CB2Q41148634-DC005DF2-E8EC-46EA-B662-3ED8AD947E18Q41695607-73C3FC46-A66D-49A2-B3F0-1F2BAED8ABADQ41744560-411967BD-BEC2-495A-9938-BB5F6AF19269Q42332526-006F91EC-4FC9-4AF2-A669-246EE42BDD8EQ42635303-94DD98AB-EBD9-4B40-850D-A4CBC4BAB037Q43939427-ECABA8D5-BDEE-4B01-A52E-4020D63F80A2Q44574350-990F6555-E09C-41C6-86D1-21044CC39710Q47665576-191DAC90-5167-4C79-A974-3F40723FBDE9Q47926830-1096D5A3-439E-44C8-8C88-2E980E67C67DQ47982310-F0E81980-2A91-46AA-B068-9782F632A95FQ48037313-A15AE2E6-CB72-4D2D-8655-E07BF0DEE588Q48038572-08022A5F-6AC2-4563-B729-69BCBB996CD2Q48049246-8C24BE94-A580-4EFE-93ED-EBE848B71C73Q48051908-AF6D11F4-0E2C-43AE-AE63-84427217419DQ48055811-B0621A34-12AC-4ED2-A00A-5141DF0114CAQ48056205-C4C7E1EE-C0E1-47E4-B3F7-4C77B2EBAB91Q48062835-05794BEF-1A76-46AA-B59A-C0396A2707ABQ48100868-C2822B33-3732-45B5-9111-8B45760FD3A2Q48111323-C247DC71-3C2D-44C8-952A-960217D8AEEB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yu-Wen Hu
@ast
Yu-Wen Hu
@en
Yu-Wen Hu
@es
Yu-Wen Hu
@nl
Yu-Wen Hu
@sl
type
label
Yu-Wen Hu
@ast
Yu-Wen Hu
@en
Yu-Wen Hu
@es
Yu-Wen Hu
@nl
Yu-Wen Hu
@sl
prefLabel
Yu-Wen Hu
@ast
Yu-Wen Hu
@en
Yu-Wen Hu
@es
Yu-Wen Hu
@nl
Yu-Wen Hu
@sl
P106
P31
P496
0000-0002-7983-415X